2021 - icahn.mssm.edu

2021Awarding of Endowed Professorships

ACADEMIC YEAR TWO THOUSAND TWENTY ONE

3

Awarding of Endowed Professorships

2

EMMA GUTTMAN-YASSKY, MD, PhDWaldman Chair of Dermatology

GIRISH N. NADKARNI, MDIrene and Dr. Arthur M. Fishberg Professor of Medicine

LOUIS R. PASQUALE, MD, FARVOShelley and Steven Einhorn Distinguished Chair of Ophthalmology

LESLEE J. SHAW, PhDMount Sinai Professor in Women’s Health Research

JOSEPH A. SPARANO, MDEzra M. Greenspan, MD Professor in Clinical Cancer Therapeutics

FILIP K. SWIRSKI, PhDThe Arthur and Janet C. Ross Professor of Medicine

RACHEL YEHUDA, PhDMount Sinai Professor in Psychiatry and Neuroscience of Trauma

BIN ZHANG, PhDWillard T.C. Johnson Research Professor of Neurogenetics

OREN J. BECHER, MDSteven Ravitch Chair in Pediatric Hematology

SUPINDA BUNYAVANICH, MD, MPH, MPhilMount Sinai Professor in Allergy and Systems Biology

KIRK N. CAMPBELL, MDIrene and Dr. Arthur M. Fishberg Professor of Medicine

KECIA N. CARROLL, MD, MPHDebra and Leon Black Professor in Pediatrics

JAIME CHU, MDMount Sinai Professor in Pediatric Liver Research

KRISTEN DAMS-O’CONNOR, PhDJack Nash Professor of Rehabilitation Medicine

THOMAS J. FUCHS, Dr.sc.Mount Sinai Chair in Artificial Intelligence and Human Health

ALISON M. GOATE, DPhilJean C. and James W. Crystal Professor of Genomics

RITA Z. GOLDSTEIN, PhDMount Sinai Professor in Neuroimaging of Addiction

4 5

New Tenured and/or Professorial RanksPRITI BALCHANDANI, PhDProfessor, Department of Diagnostic, Molecular and Interventional Radiology

MANISHA BALWANI, MD, MS Professor, Department of Genetics and Genomic Sciences

ANGELA BIANCO, MDProfessor, Department of Obstetrics, Gynecology and Reproductive Science

ANDREA D. BRANCH, PhD Professor, Samuel Bronfman Department of Medicine

ALFRED BURGER, MD Professor, Samuel Bronfman Department of Medicine

OMAR E. BURSCHTIN, MDProfessor, Samuel Bronfman Department of Medicine

KIRK N. CAMPBELL, MD Professor, Samuel Bronfman Department of Medicine

JERRY CHIPUK, PhD Associate Professor, Department of Oncological Sciences

IVAN E. DE ARAUJO, PhD Professor, Nash Family Department of Neuroscience

BRADLEY N. DELMAN, MD, MS Professor, Department of Diagnostic, Molecular and Interventional Radiology

MIROSLAV L. DJORDJEVIC, MD Clinical Professor, The Milton and Carroll Petrie Department of Urology

SIOBHAN DOLAN, MD, MPH Professor, Department of Obstetrics, Gynecology and Reproductive Science

NATALIA N. EGOROVA, PhDProfessor, Department of Population Health Science and Policy

LAWRENCE J. EPSTEIN, MD Professor, Department of Anesthesiology, Perioperative and Pain Medicine

MARIANA FIGUEIRO, PhD Professor, Department of Population Health Science and Policy

THOMAS J. FUCHS, Dr.sc. Professor, The Lillian and Henry M. Stratton-Hans Popper Department of Pathology, Molecular and Cell-Based Medicine

MICHAEL M. GAISA, MD, PhD Professor, Samuel Bronfman Department of Medicine

SAADI GHATAN, MDProfessor, Department of Neurosurgery

ROBERT GOLDBERG, DOClinical Professor, Department of Rehabilitation and Human Performance

SHERYL GREEN, MBBCh Professor, Department of Radiation Oncology

FRANCIS G. GRESS, MD Professor, Samuel Bronfman Department of Medicine

PRIYA GREWAL, MDProfessor, Samuel Bronfman Department of Medicine

ERNESTO GUCCIONE, PhD Professor, Department of Oncological Sciences

ALON HARRIS, MS, PhDAssociate Professor, Department of Ophthalmology

LEIF A. HAVTON, MD, PhDProfessor, The Estelle and Daniel Maggin Department of Neurology

GAY HOLSTEIN, PhDProfessor, The Estelle and Daniel Maggin Department of Neurology

ILIYAN IVANOV, MDProfessor, Department of Psychiatry

WALEED JAVAID, MDProfessor, Samuel Bronfman Department of Medicine

MARK D. KAUFMANN, MDClinical Professor, The Kimberly and Eric J. Waldman Department of Dermatology

AMY S. KELLEY, MD, MSHS Professor, Brookdale Department of Geriatrics and Palliative Medicine

EIMEAR E. KENNY, PhD Professor, Samuel Bronfman Department of Medicine

EDWARD KIM, MD Professor, Department of Diagnostic, Molecular and Interventional Radiology

6 7

New Tenured and/or Professorial RanksKARIN KNESAUREK, PhDProfessor, Department of Diagnostic, Molecular and Interventional Radiology

STEPHEN KRIEGER, MD Professor, The Estelle and Daniel Maggin Department of Neurology

CAROL LEVY, MD Professor, Samuel Bronfman Department of Medicine

FLORENCE MARLOW, PhD Associate Professor, Department of Cell, Developmental and Regenerative Biology

IRA S. MEISELS, MDProfessor, Samuel Bronfman Department of Medicine

RACHEL MILLER, MD Professor, Samuel Bronfman Department of Medicine

GUY H. MONTGOMERY, PhD Professor, Department of Population Health Science and Policy

CALIN S. MOUCHA, MD Professor, Leni and Peter W. May Department of Orthopedics

JAMES MURROUGH, MD, PhD Associate Professor, Department of Psychiatry

GIRISH N. NADKARNI, MD Associate Professor, Samuel Bronfman Department of Medicine

SAMIR PAREKH, MBBS Professor, Samuel Bronfman Department of Medicine

PETER PASTUSZKO, MD Professor, Department of Cardiovascular SurgeryProfessor, Jack and Lucy Clark Department of Pediatrics

ELISA R. PORT, MD Professor, The Ruth J. & Maxwell Hauser and Harriet & Arthur H. Aufses, Jr., MD Department of Surgery

ROBERTO POSADA, MD Professor, Jack and Lucy Clark Department of Pediatrics

TOWFIQUE RAJ, PhD Associate Professor, Nash Family Department of NeuroscienceAssociate Professor, Department of Genetics and Genomic Sciences

DAHLIA RIZK, DO, MPH Professor, Samuel Bronfman Department of Medicine

AMY S. ROSENBERG, MD Professor, Samuel Bronfman Department of Medicine

PANAGIOTIS ROUSSOS, MD, PhD, MS Professor, Department of Genetics and Genomic SciencesProfessor, Department of Psychiatry

JEFFREY M. SALAND, MD, MSCR Professor, Jack and Lucy Clark Department of Pediatrics

UMUT SARPEL, MD Professor, The Ruth J. & Maxwell Hauser and Harriet & Arthur H. Aufses, Jr., MD Department of Surgery

DANIELA SCHILLER, PhD Professor, Nash Family Department of NeuroscienceProfessor, Department of Psychiatry

ANDREW J. SHARP, PhD Professor, Department of Genetics and Genomic Sciences

LI SHEN, PhD Professor, Nash Family Department of Neuroscience

JEFFREY SILBIGER, MD Professor, Samuel Bronfman Department of Medicine

ANURADHA SINGH, MD Professor, The Estelle and Daniel Maggin Department of Neurology

RAINIER P. SORIANO, MDProfessor, Brookdale Department of Geriatrics and Palliative Medicine

CHRISTOPHER STURGEON, PhD Associate Professor, Department of Cell, Developmental and Regenerative Biology

FILIP K. SWIRSKI, PhDProfessor, Samuel Bronfman Department of Medicine

PHILIP R. SZESZKO, PhD Professor, Department of Psychiatry

WINDSOR TING, MD Professor, The Ruth J. & Maxwell Hauser and Harriet & Arthur H. Aufses, Jr., MD Department of Surgery

8 9

New Tenured and/or Professorial RanksANTONIO URBINA, MD Professor, Samuel Bronfman Department of Medicine

VISWANATH VASUDEVAN, MD Clinical Professor, Samuel Bronfman Department of Medicine

MENACHEM WEINER, MD Professor, Department of Anesthesiology, Perioperative and Pain Medicine

PETER WIKLUND, MD, PhDProfessor, The Milton and Carroll Petrie Department of Urology

EDWARD WOLIN, MDProfessor, Samuel Bronfman Department of Medicine

MAUREEN F. ZAKOWSKI, MD Professor, The Lillian and Henry M. Stratton-Hans Popper Department of Pathology, Molecular and Cell-Based Medicine

Institute for Medical EducationCurrent Fellow Educator MembersCYNTHIA ABRAHAM, MD

JACOB APPEL, MD, JD, MPH, MPhil, MFA, MS, MA

MOLLIE BIEWALD, MD

LOIS BRUSTMAN, MD

ALFRED BURGER, MD, MSc

NISHA CHADHA, MD

LINDA DECHERRIE, MD

CARRIE ERNST, MD

SAMIRA FAROUK, MD, MSCR

JOEL FORMAN, MD

ERIC GANZ, MD

ALLISON GAULT, MD

CHRISTOPHER HAHN, MD

ADAM HILL, MD

WING WA HO, MD

KEVIN HU, MD

HARISH JASTI, MD

NOELLE JAVIER, MD

CRAIG KATZ, MD

DANIEL KATZ, MD

TONIA KIM, MD

AMIE KIM, MD, CAQSM

FRED KO, MD

JARED KUTZIN, DNP, MS, MPH, RN

WHITNEY LIEB, MD, MPH, MSCR

ANTHONEY LIM, MD, MS

ELIZABETH LINDENBERGER, MD

BRYAN MAHONEY, MD

ALEFIYAH MALBARI, MD

CHAD MEYERS, MD

LEORA MOGILNER, MD

LAUREN PECCORALO, MD, MPH

KAMRON POURMAND, MD

ELAINE RABIN, MD

GWEN RAPHAN, MD

CHRISTOPHER RICHARDSON, MD

JAMES SALONIA, MD

MARTINE SANON, MD

TURANDOT SAUL, MD

EILEEN SCIGLIANO, MD

ELIZABETH SINGER, MD, MPH

LOUIS SPINA, MD

LAURA STEIN, MD, MPH

JENNIFER WEINTRAUB, MD

As of September 2021

10 11

Institute for Medical EducationCurrent Master Educator Members SAADIA AKHTAR, MD

DAVID BECHHOFER, PhD

JENNIFER BECK-ESMAY, MD

SUZANNE BENTLEY, MD, MPH

KATHERINE CHEN, MD, MPH

ANDREW COYLE, MD

ROBERT FALLAR, PhD

HELEN FERNANDEZ, MD, MPH

PETER GLIATTO, MD

JOANNE HOJSAK, MD

STEVEN ITZKOWITZ, MD

ANDY JAGODA, MD

REENA KARANI, MD, MHPE

CYNTHIA KATZ, MD

STACI LEISMAN, MD

ADAM LEVINE, MD

LAURA MACISAAC, MD

MARIA MALDONADO, MD

DAVID MULLER, MD

BRET NELSON, MD

ANN-GEL PALERMO, DrPH

VALERIE PARKAS, MD

PARU PATRAWALLA, MD

ALEXANDROS POLYDORIDES, MD, PhD

ROBERTO POSADA, MD

RAVISHANKAR RAMASWAMY, MD

DAVID SACHAR, MD

JENNIFER SANDERS, MD

BRIJEN SHAH, MD

RAINIER SORIANO, MD

MARC STONE, MD

JAMES STRAIN, MD

CHRISTOPHER STROTHER, MD

TALIA SWARTZ, MD, PhD

PETER TAUB, MD

DAVID THOMAS, MD


Honors and Awards: 2020-2021 Academic YearJACOB APPEL, MD Associate Professor, Department of Psychiatry Co-Chair, Committee on Psychiatry & Law, Group for the Advancement of Psychiatry

HEIDI BAER, MD Associate Professor, Department of Emergency Medicine National Emergency Medicine Faculty Teaching Award, American College of Emergency Physicians (ACEP)

SHAHLA BAHARLOU, MD Associate Professor, Brookdale Department of Geriatrics and Palliative Medicine Chair, Geriatrics Commission, Society of General Internal Medicine

STEPHANIE BEHRINGER-MASSERA, MD Assistant Professor, Samuel Bronfman Department of Medicine Outstanding Abstract Award, Endocrine Society

STEPHANIE BLANK, MD Professor, Department of Obstetrics, Gynecology, and Reproductive Science Member, The Tisch Cancer InstituteMember, The Blavatnik Family Women’s Health Research Institute President Elect, Society of Gynecologic OncologyBoard of Directors, Foundation for Women’s CancerChair, Gender Equity Task Force Society of Gynecologic OncologyBoard of Directors, SHAREBoard of Directors, Society of Gynecologic OncologyBoard of Directors, National Ovarian Cancer Coalition

THOMAS BRYCE, MD Professor, Department of Rehabilitation and Human Performance Fellow, American Spinal Injury Association

SUPINDA BUNYAVANICH, MD, MPH, Phil Professor, Department of Genetics and Genomic Sciences Member, The Mindich Child Health and Development Institute Keynote Speaker, University of Michigan

ALFRED BURGER, MD Associate Professor, Samuel Bronfman Department of Medicine Chair, Digital Learning Committee, Society of Hospital MedicineMid Atlantic Award for Leadership, Society of General Internal Medicine

YVETTE CALDERON, MD Professor, Department of Emergency Medicine Chair of the Diversity, Equity, and Inclusion Committee, American Board of Emergency Medicine

12 13

Honors and Awards: 2020-2021 Academic YearBRENDON CARR, MD, MA, MS Chair and Professor, Department of Emergency Medicine Elected Member, National Academy of Medicine

FRANCESCA COSSARINI, MD Assistant Professor, Samuel Bronfman Department of Medicine, Division of Infectious DiseasesYoung Investigator Award, Conference on Retroviruses and Opportunistic Infections

KRISTEN DAMS-O’CONNOR, PhD Professor, Department of Rehabilitation and Human Performance Member, The Friedman Brain Institute Edward Lowman Award American Congress of Rehabilitation MedicineChair, Common Data Elements Working Group for Postmortem Clinical Characterization in TBI, National Institutes of Health

SILVIA DE RUBEIS, PhD Assistant Professor, Department of Psychiatry Member, Seaver Autism CenterMember, The Mindich Child Health and Development InstituteMember, The Friedman Brain Institute Friedrich Wilhelm Bessel Research Award, Alexander von Humboldt Foundation

ROBERT DESNICK, MD, PhD Chair Emeritus and Professor, Department of Genetics and Genomic Sciences Fellow, National Academy of Inventors

BURTON P. DRAYER, MD, FACR, FAAN Dr. Charles M. and Marilyn Newman ProfessorSystem Chair and Professor, Department of Diagnostic, Molecular, and Interventional Radiology 2020 Distinguished Radiology Award, New York Roentgen Society

KENNY EIMEAR, PhD Director, The Institute for Genomic Health Professor, Samuel Bronfman Department of Medicine Member, The Institute for Genomic Health Keynote Speaker, International Conference on Quantitative Genetics; Brisbane, AustraliaKeynote Speaker, Irish Society of Human Genetics, Dublin, IrelandKeynote Speaker, Computational Genomics and Systems Biology Symposium, Galway, IrelandAdvisory Board, Science Foundation, Ireland, Center for Research Training in Genomics Data ScienceAdvisory Board, Cell Genomics

ANA FERNANDEZ-SESMA, PhD Professor, Department of Microbiology Keynote Speaker, Universidad de Santiago de Compostela, Spain; III Annual CiMUS Workshop Keynote Speaker, Association for Science Teacher Education Northeast Keynote Speaker, University of Salamanca, SpainElected Fellow, American Academy of MicrobiologyElected Chair, NIH/NIAID Human Immunology Project Consortia (HIPC) Steering Committee

DINALI FERNANDO, MD Associate Professor, Department of Emergency Medicine Pearl Birnbaum Hurwitz (PBH) Humanism in Healthcare Award Recipient and Conference Panelist, Arnold P. Gold Foundation

VALENTIN FUSTER, MD, PhD Director of the Zena and Michael A. Wiener Cardiovascular InstitutePhysician-in-Chief, The Mount Sinai HospitalRichard Gorlin, MD/Heart Research Foundation Professor Professor, Samuel Bronfman Department of Medicine Heart of Gold Legacy Award, American Heart Association Prince Mahidol Award in the Field of Medicine, Royal Family of Thailand, Bangkok, ThailandMaster of Cardiology and Medicine, University of MexicoLifetime Achievement Award, Transcatheter Cardiovascular Therapeutics (TCT) Gold Medal by the Cardiac Imaging Association, Spanish Society of Cardiology, SpainMaimonides Award & Gold Medal of the The Coroba College of Physicians, The Cordova College of Physicians - Coroba, Spain

ADOLFO GARCIA-SASTRE, PhD Director, Global Health and Emerging Pathogens InstituteIrene and Dr. Arthur M. Fishberg Professor of Medicine Professor, Department of Microbiology Member, Global Health and Emerging Pathogens Institute Admirables Prize, Diario Médico, Spain

ALAN GARELY, MD Professor, Department of Obstetrics, Gynecology, and Reproductive Science Chair, Advisory Council of Gynecology and Obstetrics, American College of Surgeons

SOMALI GAVANE, MD Assistant Professor, Department of Diagnostic, Molecular, and Interventional Radiology Personal Best Mentor of the Year, American Collge of Nuclear Medicine President’s Award, American College of Nuclear Medicine

MICHAEL GELMAN, MD, PhD Assistant Professor, Samuel Bronfman Department of Medicine, Division of Infectious Diseases Co-Chair, National COVID-19 Testing Clinical Guidance Workgroup, Veterans Health Administration

14 15

Honors and Awards: 2020-2021 Academic YearAARON GLATT, MD Professor, Samuel Bronfman Department of Medicine Mastership, American College of Physicians (MACP) Laureate Award, American College of Physicians, NY Chapter

ALICE GOTTLIEB, MD, PhD Professor, Kimberly and Eric J. Waldman Department of Dermatology Founding Director, Autoimmune Disease Center, International Dermatology Outcomes Measures Group

ERNESTO GUCCIONE, PhD Professor, Department of Oncological Sciences Keynote Speaker, Protein Arginine Methylation: Recent Advances in Basic and Translational Studies, Abcam Webinar

EMMA GUTTMAN-YASSKY, MD, PhD Director, Center of Excellence in EczemaDirector, Laboratory of Inflammatory Skin DiseasesProfessor, Kimberly and Eric J. Waldman Department of Dermatology Donald Y. M. Leung, MD, PhD-JACI Editors Lectureship and Faculty Development Award, American Academy of Allergy, Asthma, and ImmunologyKeynote Speaker, Korean Academy of Pediatric Allergy and Respiratory Disease/Asia Pacific Association of Pediatric Allergy and Immunology Joint CongressKeynote Speaker, Swiss Society for Dermatology and Venerology

NOAM HAREL, MD, PhD Associate Professor, The Estelle and Daniel Maggin Department of Neurology Chair, Spine Section, American Academy of NeurologyBoard of Directors, American Society of Neurorehabilitation

ALON HARRIS, PhD, MS Professor, Department of Ophthalmology Member, Eye and Vision Research Institute Keynote Lecturer, Bruno Boles Carenini Awards: IOP, Ocular Blood Flow and Cerebro-Spinal Fluid in Glaucoma 4th Italian Association for the Study of Glaucoma (AISG) International Conference, Rome, Italy

FRED HIRSCH, MD, PhD Joe Lowe and Louis Price Professor of Medicine Professor, Samuel Bronfman Department of Medicine, Division of Hematology and Medical OncologyLung Cancer Hero 2020, American Society of Clinical Oncology, Cure Magazine/MJH Life Science IASLC names “Fred R. Hirsch Lectureship Award for Translational Research” Presented Annually at World Lung Conference, International Association for The Study of Lung CancerChair Role: Chair of Molecular Database Committee, International Association for The Study of Lung Cancer

RONALD HOFFMAN, MD Professor, Samuel Bronfman Department of Medicine, Division of Hematology and Medical OncologyChair of Live Tumor Board for Polycythemia Vera and Myelofibrosis, Physicians’ Education Resources (PER CME)

AMIR HOROWITZ, PhD Assistant Professor, Department of Oncological Sciences Member, Precision Immunology InstituteMember, The Tisch Cancer Institute Keynote Speaker, William Blair / Maidstone Life Sciences

JUDITH HOWE, PhD, MPA Professor, Brookdale Department of Geriatrics and Palliative Medicine Chair, Academy for Gerontology in Higher Education, Gerontological Society of America

NATHALIE JETTE, MD, MS Bluhdorn Professor of International Medicine Professor, The Estelle and Daniel Maggin Department of Neurology Member, Institute of Health Care Delivery ScienceMember, The Friedman Brain Institute Chair Task Force on Clinical Practice Guidelines, International League Against Epilepsy Elected Executive Board Member, American Epilepsy Society Chair, Driving Task Force, International League Against EpilepsyExecutive Board Member, International League Against EpilepsyCongress Chair, First North American Epilepsy Meeting, International League Against EpilepsyChair, International League Against Epilepsy, North America

REENA KARANI, MD, MHPE Director, Institute for Medical Education Professor, Department of Medical Education Member of the Board, American Geriatrics SocietyChair, USMLE Patient Characteristics Advisory Committee, National Board of Medical Examiners

SUSAN KHALIL, MD Assistant Professor, Department of Obstetrics, Gynecology, and Reproductive science Chair of Quality Improvement and Patient Safety Committee, American Association of Gynecologic Laparoscopists/Fellowship in Minimally Invasive Gynecologic SurgeryACOG’s 2021 Council of District Chairs Service Recognition Award, American College of Obstetricians and Gynecologists

SANJANA KOSHY, MD Assistant Professor, Samuel Bronfman Department of Medicine Infectious Diseases Society of America, Antimicrobial Stewardship Center of Excellence

MARK LEBWOHL, MD Dean for Clinical Therapeutics Professor, Kimberly and Eric J. Waldman Department of DermatologyDistinguished Leadership Award, American Skin AssociationOutstanding Educator in Psoriatic Disease Award, National Psoriasis Foundation

ERIC LEGOME, MD Professor, Department of Emergency Medicine Chair, Continuous Competency and Certification Committee, American College of Emergency Physicians (ACEP)

16 17

Honors and Awards: 2020-2021 Academic YearMICHELLE LIN, MD, MPH, MS Associate Professor, Department of Emergency Medicine Young Investigator Award, Society for Academic Emergency Medicine (SAEM)

ROBERT LOOKSTEIN, MD Professor, Department of Diagnostic, Molecular, and Interventional Radiology President, PERT Consortium (Pulmonary Embolism Response Team)

FRED LUBLIN, MD Saunders Family Professor of Neurology Professor, The Estelle and Daniel Maggin Department of Neurology Chair, NINDS Multiple Sclerosis Common Data Elements Working Group, Sept 2010 - Present, NIH/NINDS (National Institute of Neurological Disorders and Stroke)

LAURIE MARGOLIES, MD Professor, Department of Diagnostic, Molecular, and Interventional Radiology Chair, Committee on Breast Ultrasound Accreditation, American College of RadiologyChair, SBI Mentorship Committee, Society of Breast ImagingDirector at Large and Equity Director, Society of Breast Imaging

MIRIAM MERAD, MD, PhD Mount Sinai Professor in Cancer ImmunologyDirector, Precision Immunology InstituteProfessor, Department of Oncological Sciences Elected Member, National Academy of Sciences

JUAN MEZZICH, MD, PhD, MS, MA Professor, Department of Psychiatry Keynote Lecture, 8th International Congress of Person Centered Medicine, “The paradigmatic role of person centered health in response to the pandemic”, Pan American Health Organization / World Health OrganizationHonorary Professor, Cattedra Onoraria on Person Centered Medicine, Ambrosiana University Milan School of Medicine, Milan, Italy

RACHEL MILLER, MD Dr. David and Dorothy Merksamer Professor of Medicine (Allergy and Immunology) Professor, Samuel Bronfman Department of Medicine I. Leonard Bernstein, MD FAAAAI Memorial Lectureship at the AAAAI/ACAAI Joint Congress for delivering the talk “Effects of Chemical Pollution and Xenobiotics on Epigenetics of Allergic Disease”,American Academy of Allergy, Asthma and Immunology

NIAMH MULLINS, PhD Assistant Professor, Department of Genetics and Genomic Sciences Assistant Professor, Department of PsychiatryGershon Paper of the Year Award, International Society of Psychiatric Genetics

HETANSHI NAIK, PhD, MS Assistant Professor, Department of Genetics and Genomic Sciences Member, Institute for Transformative Clinical Trials Nominated for NSGC Leadership Award, National Society of Genetics Counselors

ERIC NESTLER, MD, PhD Dean for Academic Affairs Chief Science Officer, Mount Sinai Health SystemInstitute Director, The Friedman Brain InstituteNash Family Professor, Nash Family Department of Neuroscience Member, The Friedman Brain Institute Doctor of Science, honoris causa, Concordia University

ANNA PACE, MD Assistant Professor, The Estelle and Daniel Maggin Department of Neurology Keynote Plenary Lecture at Annual Scientific Meeting, American Headache Society

RAMON PARSONS, MD, PhD Ward-Coleman Chair in Cancer ResearchDirector, The Tisch Cancer InstituteChair and Professor, Department of Oncological Sciences Keynote Speaker Virtual Endometrial Cancer, American Association for Cancer Research

LOUIS PASQUALE, MD Director, The Tisch Cancer Institute Professor, Department of Ophthalmology Member, Eye and Vision Research Institute Invited Speaker, The Robert P. Burns and Lynette Feeney Burns, PhD Virtual Professor Hosted by Mason Eye Institute, Columbia, MissouriInvited Speaker, University of IowaInvited Speaker, 783rd Meeting of the New England Ophthalmological Society (virtual)Physician Scientist Guest of Honor, USC Roski Eye Institute Glaucoma CME 2021

LYNNE RICHARDON, MD Professor, Department of Emergency Medicine Chair of NIH Study Section, Health Services Quality and Effectiveness (HSQE)

RICHARD ROSEN, MD Professor, Department of Ophthalmology Honorary Professor of Applied Optics, University of Kent, Department of Applied PhysicsChairman, ARVO Multidisciplinary Ophthalmic Imaging Program Committee, Association of Research in Vision and OphthalmologyChairman, AAO Museum of the Eye Program Committee American Academy of Ophthalmology

KENNETH ROSENZWEIG, MD System Chair and Professor, Department of Radiation Oncology Elliot Osserman Award from the Israel Cancer Research Fund, Israel Cancer Research Fund

18 19

Honors and Awards: 2020-2021 Academic YearREENA RUPANI, MD Assistant Professor, Kimberly and Eric J. Waldman Department of Dermatology Chair, American Academy of Dermatology Expert Resource Group on Integrative Dermatology

LISA SATLIN, MD Herbert H. Lehman Professor of Pediatrics System Chair and Professor, Jack and Lucy Clark Department of Pediatrics Board of Directors, American Physician Scientists Association

JOSEPH SPARANO, MD Professor, Samuel Bronfman Department of Medicine Member, The Tisch Cancer Institute Gianni Bonadonna Award, American Society of Clinical Oncology

DANIEL STEINBERG, MD Associate Professor, Samuel Bronfman Department of Medicine Chair, Annual Scientific Meeting Society of Hospital MedicineParker J. Palmer Courage to Teach Award, Accreditation Council on Graduate Medical Education

TALIA SWARTZ, MD, PhD Associate Dean for MD/PhD Education Assistant Professor, Samuel Bronfman Department of Medicine Fellow, Infectious Diseases Society of AmericaChair, AAMC GREAT MD-PhD Section Communications CommitteeJunior Faculty Research Award, Infectious Diseases Society of New York

JAMES TSAI, MD, MBA Delafield-Rodgers Professor of Ophthalmology Chair and President, New York Eye and Ear Infirmary of Mount Sinai Professor, Department of Ophthalmology Member, Eye and Vision Research Institute Albert Nelson Marquis Lifetime Achievement Award, Marquis Who’s Who Lifetime AcheivementSecretariat Award, American Academy of OphthalmologyUSC Roski Eye Institute Distinguished Alumni Award LectureBoard of Directors, Chinese American Medical Society (CAMS)President-Elect, International Join Commission on Allied Health Professionals in Ophthalmology (IJCAHPO)

BARBARA VICKREY, MD, MPH Henry P. and Georgette Goldschmidt Professor of Neurology System Chair and Professor, The Estelle and Daniel Maggin Department of Neurology Vice President, Association of University Professors of Neurology Chair, Media Engagement Subcommittee, Association of University Professors of NeurologyCo-Chair, Clinical Networks Evaluation Working Group, National Institute of Neurological Disorders and Stroke

DANIEL WACKER, PhD Assistant Professor, Department of Pharmacological Sciences McKnight Foundation Scholar Award, McKnight Foundation

JULIE WANG, MD Professor, Jack and Lucy Clark Department of Pediatrics Chair, Executive Committee of the Section on Allergy and Immunology, American Academy of PediatricsChair, Leadership Institute, American Academy of Allergy Asthma and Immunology

KRIS WHITE, PhD Assistant Professor, Department of Microbiology Member, Global Health and Emerging Pathogens Institute Keynote Speaker, Virginia Drug Discovery Consortium

JUAN WISNIVESKY, MD, DrPH Irene and Dr. Arthur M. Fishberg Professor of Medicine Professor, Samuel Bronfman Department of Medicine BSHSR Assembly Lifetime Achievement Award, American Thoracic Society

ALEXIS ZEBROWSKI, PhD, MPH Assistant Professor, Department of Emergency Medicine Research Achievement Award in the Young Investigator Category, Society for Academic Emergency Medicine (SAEM)

The Mount Sinai Hospital 2021 U.S. News & World Report

“BEST HOSPITALS” RANKINGS

For the sixth year in a row, The Mount Sinai Hospital has been listed on the esteemed “Honor Roll” in the U.S. News & World Report “Best Hospitals” rankings. The Hospital

ranks No. 17 nationally among the nation’s top 20 hospitals for care excellence.

The Mount Sinai Hospital Ranked in the Top 50 in the Nation in 10 Specialties:

The Mount Sinai Hospital ranked as “High Performing” in 13 common conditions and procedures:

• Abdominal aortic aneurysm repair• Aortic valve surgery• Chronic obstructive pulmonary disease• Colon cancer surgery• Diabetes• Heart attack• Heart bypass surgery• Heart failure• Kidney failure• Lung cancer surgery• Pnemonia• Stroke• Transcatheter aortic valve replacement

Brookdale Department of Geriatrics and Palliative Medicine#1 Specialty Rankings

GERIATRICS

#1CARDIOLOGY/

HEART SURGERY

#6DIABETES/

ENDOCRINOLOGY

#10

NEPHROLOGY

NEUROLOGY/NEUROSURGERY

#10

ORTHOPEDICS

#14

PULMONOLOGY/LUNGSURGERY

#20

CANCER

#32

Mount Sinai Office of Developmentgiving.mountsinai.org

The Tisch Cancer Institute (TCI) has moved up from: 32 49

Thanks to the team of award-winning clinicians and researchers whose integrated, collaborative approach to cancer care expertise continues to propel the Institute’s work and has earned us Designated Cancer Center status from the National Cancer Institute.

EAR, NOSE, AND THROAT

#24

UROLOGY

#16GASTROENTEROLOGY/

GI SURGERY

#15

REHABILITATION

#14

For the 2nd year in a row Geriatrics/Palliative Care is #1

Cancer Moves Up in Rankings

The Mount Sinai Health System: Recent Notable Awards and Honors

The Mount Sinai Hospital is recognized as No. 3 in Gastroenterology, No. 4 in Cardiology and Cardiac Surgery, No. 6 in Pulmonology, and No. 8 in Neurosurgery on Newsweek’s World’s Best Specialty Hospital 2022 List.The Hospital also ranked No. 11 in Neurology, No. 22 in Oncology, No. 23 in Pediatrics, No. 25 in Orthopedics, and No. 29 in Endocrinology.

The Mount Sinai Hospital is recognized as No. 4 on Newsweek’s World’s Best Smart Hospitals 2021.The Hospital ranked No. 1 in the New York City metropolitan area and No. 4 globally among the most technologically advanced health care institutions.

The Mount Sinai Hospital is recognized in Top 20 on Newsweek’s World’s Best Hospitals 2021 List.The Mount Sinai Hospital has again earned top honors on Newsweek’s list of World’s Best Hospitals 2021. The hospital was ranked No. 1 in the New York metropolitan region and No. 19 among hospitals in the world.

The Mount Sinai Hospital has achieved “Honor Roll” status in the U.S. News & World Report “Best Hospitals” rankings (2021/2022).Mount Sinai was ranked No. 17 in the nation on the “Honor Roll”—a distinction awarded to centers that perform at the highest levels in three or more specialties. This is the 6th consecutive year that Mount Sinai has been on the honor roll.

Icahn School of Medicine is once again ranked among the top 20 medical schools for research in the United States (2021/2022).According to the 2022 U.S. News & World Report “Best Medical Schools” rankings released in March 2021, Icahn Mount Sinai ranked No. 17 among the medical schools and schools of osteopathic medicine that were ranked this year, an improvement of four places over last year.

Icahn School of Medicine Ranked 14th in NIH Funding (2020).The Icahn School of Medicine at Mount Sinai is ranked 14th among 139 medical schools in the U.S. for National Institutes of Health (NIH) awards in 2020. Specific departments are also ranked among the top 10 nationally in NIH funding per principal investigator. This reflects a special level of excellence in education, clinical practice, and research as recognized by peers within the scientific community.

Forbes ranks the Mount Sinai Health System 19th out of 500 companies on its list of America’s Best Employers for Diversity (2020). The Mount Sinai Hospital has again earned top honors on Newsweek’s list of World’s Best Hospitals 2021. The hospital was ranked No. 1 in the New York metropolitan region and No. 19 among hospitals in the world.

Mount Sinai Health SystemOffice of Development | 212-659-8500 | giving.mountsinai.org

22 23

Biographies: Endowed ProfessorsSteven Ravitch Chair in Pediatric Hematology

Professorships representing a personal or family interest in a particular disease area, like the Steven Ravitch Chair in Pediatric Hematology, are meaningful and critical to Mount Sinai’s scientific achievements. This Chair is named in memory of Mr. Richard Ravitch’s late son, Steven, with his former wife Diane Ravitch. Steven died of Leukemia in 1966 at the age of two. This endowment has supported Pediatric Hematology research at Mount Sinai for 30 years; it was originally created as the Steven Ravitch Memorial Fellowship in Pediatric Hematology in 1991, and in 2005 with additional funding from Mr. Ravitch, it became the Steven Ravitch Chair in Pediatric Hematology. The Ravitch family’s tireless commitment and generous contributions have played an integral part in Mount Sinai’s efforts to advance Pediatric Hematology research and education.

Mr. Ravitch has a longstanding history of philanthropy and service to Mount Sinai as a member of the Boards of Trustees for more than 35 years. In addition to his philanthropic contributions, Mr. Ravitch has generously given his experience and knowledge to Mount Sinai, providing the institution with much guidance and acumen through his various leadership roles and his committed support of Trustee initiatives. During Mr. Ravitch’s career as a lawyer, businessman, and public official, he held such varied roles as Chairman of the HRH Construction Corporation, Chairman and CEO of the Metropolitan Transportation Authority (MTA), Chairman of the New York State Urban Development Corporation, leader of an effort to recapitalize The Bowery Savings Bank, President of the Player Relations Committee for Major League Baseball, chair of a Commission that designed a plan to finance the MTA, and Lieutenant Governor of the State of New York under former Governor David Paterson.

OREN J. BECHER, MDSteven Ravitch Chair in Pediatric Hematology

Oren J. Becher, MD, is the Chief of the Jack Martin Division of Pediatric Hematology-Oncology at Mount Sinai Kravis Children’s Hospital and Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai. Dr. Becher is a physician-scientist focused on improving the standard of care for children with brain tumors, particularly diffuse intrinsic pontine glioma—or, DIPG—an incurable pediatric brain cancer.

He joined Mount Sinai in 2021 from the Northwestern University School of Medicine where in addition to appointments in the Department of Pediatrics and the Department of Biochemistry and Molecular Genetics, he also maintained clinical responsibilities at Ann & Robert H. Lurie Children’s Hospital of Chicago.

By studying the function of the genetic alterations present in DIPG, Dr. Becher’s laboratory co-discovered the presence of somatic activating mutations in a gene not previously implicated in cancer, called ACVR1 or ALK2, in 25 percent of children with DIPG, and subsequently developed genetically engineered mouse models that recapitulate the genetic alterations of the human disease. Additionally, Dr. Becher’s laboratory has expanded efforts to develop models for other pediatric brain cancer subtypes, using these models to study the tumor microenvironment and to evaluate novel therapeutics that help prioritize clinical trials for children with DIPG.

Dr. Becher obtained his Bachelor of Arts degree from the University of Pennsylvania and his medical degree from Johns Hopkins School of Medicine. He completed his pediatric residency at the Children’s National Medical Center in Washington, D.C. and fellowships in pediatric hematology-oncology and neuro-oncology at Memorial Sloan Kettering Cancer Center.

24 25

Mount Sinai Professor in Allergy and Systems Biology

The Mount Sinai Professorships were established in 2007 by the Mount Sinai Boards of Trustees to honor the achievements and contributions of some of the Icahn School of Medicine’s most outstanding faculty. As of 2021, a total of 28 faculty will occupy Mount Sinai Professorships in Affective Neuroscience, Allergy and Systems Biology, Alzheimer’s Research, Artificial Intelligence, Bioinformatics, Biomedical Data Science, Cancer Biology, Cancer Immunology, Cardiovascular Clinical Research and Outcomes, Cardiovascular Surgery, Cell Biology, Developmental Genetics, Molecular Pharmacology, Multiple Myeloma, Neuroimaging, Neurotherapeutics, Orthopedics, Orthopedic Research, Pediatric Liver Research, Perioperative Care, Predictive Health and Computational Biology, Psychiatric Epigenomics, Psychiatry and Neuroscience of Trauma, Structural Biology, Therapeutics Discovery, Vaccinology, Vascular Surgery, and Women’s Health Research.

Biographies: Endowed Professors

SUPINDA BUNYAVANICH, MD, MPH, MPhilMount Sinai Professor in Allergy and Systems Biology

Supinda Bunyavanich, MD, MPH, MPhil, is a Professor of Pediatrics and Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. Dr. Bunyavanich is also a practicing allergist and immunologist and the Associate Director of the Jaffe Food Allergy Institute.

Dr. Bunyavanich’s research, funded by the National Institutes of Health (NIH), combines tools in epidemiology, multi-omics, and systems biology to elucidate and

understand the pathobiology of asthma and allergic diseases. Her research group works with human cohorts to identify risk factors, mechanisms, and potential therapies for these disorders using data science and integrative -omics approaches. Findings from her lab include the identification of a nasal biomarker of asthma by machine learning analyses of nasal transcriptome data, characterization of the airway and gut microbiomes in asthma and food allergy, and identification of master regulator genes of peanut allergy and asthma.

In addition to directing a research group at Mount Sinai, Dr. Bunyavanich provides patient care as a clinical allergist and immunologist, teaches medical and graduate students, and mentors pre- and post-doctoral trainees. She has mentored more than 70 trainees who have gone on to graduate and medical school and faculty positions. Dr. Bunyavanich is a frequent invited speaker at national and international meetings, and serves as a grant reviewer and on advisory groups for the NIH. Dr. Bunyavanich received the Harvard Medical School Shore Award for Scholars in Medicine and is recognized as a Castle Connelly Exceptional Woman in Medicine.

Dr. Bunyavanich earned her undergraduate degree from Harvard University, MD from Harvard Medical School, MPH from the Harvard School of Public Health, and MPhil from the University of Cambridge. She completed her internal medicine residency at Massachusetts General Hospital-Harvard Medical School, her allergy and immunology fellowship at Brigham & Women’s Hospital-Harvard Medical School, and her postdoctoral research fellowship at the Channing Division of Network Medicine, Brigham & Women’s Hospital-Harvard Medical School.

26 27

Biographies: Endowed ProfessorsIrene and Dr. Arthur M. Fishberg Professor of Medicine

During their lifetimes, Arthur M. Fishberg, MD, and his wife, Irene, were integral members of the Mount Sinai family. Dr. Fishberg was a distinguished nephrologist and a leading authority on hypertension. His longstanding, devoted professional affiliation with Mount Sinai commenced in 1926 when he began his residency. When Mount Sinai School of Medicine opened in 1963, Dr. Fishberg was appointed Clinical Professor of Medicine and served in this capacity until 1977. For his pioneering spirit, far-reaching pro-fessional achievements, and service to the institution, he received the Jacobi Medallion in 1978, The Mount Sinai Alumni Association’s most coveted award, and in 1979 was bestowed an honorary Doctor of Science degree from the School of Medicine. Dr. Fishberg also had a passion for research, which he translated into the Irene and Dr. Arthur M. Fishberg Professor of Medicine endowment, established by his estate in 1993. There are currently nine Fishberg Professorships of Medicine at Mount Sinai.

KIRK N. CAMPBELL, MDIrene and Dr. Arthur M. Fishberg Professor of Medicine

Kirk N. Campbell, MD, is Associate Professor of Medicine (Nephrology), Vice Chair for Diversity and Inclusion, and Director of the Nephrology Fellowship Program at the Icahn School of Medicine at Mount Sinai. Dr. Campbell is a physician-scientist working to characterize novel pathways in kidney podocyte injury and survival. His clinical interest is in human glomerular disease.

In addition to treating patients, Dr. Campbell advances the understanding of the underlying mechanisms of glomerular disease progression while identifying potential targets for therapeutic intervention. He leads an NIH-funded research program focused on podocyte cell biology, experimental glomerular disease, and clinical trials in the rare kidney disease space. Key findings include the identification of dendrin and the Hippo pathways target Yes-associated protein (YAP) as regulators of podocyte survival and plasminogen as a targetable biomarker in glomerular disease. Dr. Campbell has been a principal investigator for clinical trials testing the safety and efficacy of agents in development for focal segmental glomerulosclerosis, IgA nephropathy, membranous nephropathy, and lupus nephritis.

Dr. Campbell received his medical degree from the University of Connecticut and completed his internal medicine residency at Yale University before conducting clinical and research training in nephrology at Mount Sinai. He is an elected member of the American Society for Clinical Investigation, Past-President of the New York Society of Nephrology, a member of the Board of Directors of the Nephcure Foundation, and a standing member of the Pathobiology of Kidney Disease study section at the National Institutes of Health. Dr. Campbell also serves on the Medical Advisory Board of the National Kidney Foundation of Greater New York, and is a member of the American Society of Nephrology’s grants review and kidney week education committees.

28 29

Debra and Leon Black Professor in Pediatrics

The Debra and Leon Black Professor in Pediatrics was established in 1998 through the generosity of Leon Black, a Trustee of the Mount Sinai Health System, and his wife Debra. The Blacks began their philanthropic roles at Mount Sinai in 1987 by serving as members of the Mount Sinai Associates Program and the Mount Sinai Children’s Center. Their support for advancing medical knowledge on classifying, preventing, and ameliorating childhood diseases has been essential to enhancing research efforts at Mount Sinai. They established the celebrated Black Family Stem Cell Institute in 2005. Mr. Black is a founding partner of the Apollo Organization, and Mrs. Black is a theatrical producer.


KECIA N. CARROLL, MD, MPHDebra and Leon Black Professor in Pediatrics

Kecia N. Carroll, MD, MPH, is Chief of the Division of General Pediatrics, Professor of Pediatrics, and Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai. Dr. Carroll is a board-certified general pediatrician, clinical investigator, and epidemiologist. She joined Mount Sinai in 2021 from Vanderbilt University Medical Center, where in addition to a faculty appointment in the Department of Pediatrics, she also served as the Director of Faculty Inclusion and Diversity in the Pediatric Office of Faculty Development, and Chair of the Diversity

Committee for the Master of Public Health program.

While at Vanderbilt, Dr. Carroll spearheaded efforts to foster an inclusive environment and created mentoring and career development opportunities for faculty, trainees, and students. She serves as a mentor for faculty and trainees across various career stages and academic tracks. Through her K24 Midcareer Investigator Award funded by the National Heart, Lung & Blood Institute through the National Institutes of Health, she mentors early career investigators and contributes to efforts supporting research mentor training.

Dr. Carroll’s current NIH-funded research program investigates how environmental exposures—including stress, nutritional exposures, and environmental toxicants—during critical periods of development influence childhood asthma risk, with a focus on potential modifiable risk factors. At Mount Sinai, she collaborates with investigators across the Health System, including within the Institute for Exposomic Research.

Dr. Carroll obtained her Bachelor of Arts degree from Vassar College and her medical degree from Vanderbilt University School of Medicine. She completed her pediatric residency at the University of California San Francisco and a general academic pediatrics research fellowship at Vanderbilt.

30 31

Mount Sinai Professor in Pediatric Liver Research



JAIME CHU, MDMount Sinai Professor in Pediatric Liver Research

Jaime Chu, MD, is the Associate Chief of the Division of Pediatric Hepatology, Medical Director of Pediatric Liver Transplantation, and Director of the Pediatric Physician-Scientist Residency Program at Mount Sinai Kravis Children’s Hospital and the Recanati/Miller Transplantation Institute at Mount Sinai, where she mentors resident and fellow trainees interested in pursuing a career as a physician-scientist.

Dr. Chu is a physician-scientist in pediatric hepatology. Her long-term goal is to utilize collaborative science and integrate basic and clinical research towards improving our understanding of the mechanisms underlying pediatric liver disease and to apply this knowledge towards the development of much needed therapeutic options for children with liver disease. She is the Director of the Molecular Liver Physiology and Metabolism Lab, where she leads a basic research group that focuses on how sugar metabolism pathways work together to regulate liver development and disease. Dr. Chu’s team capitalizes on the strength of the zebrafish as a tool to investigate metabolic mechanisms of liver fibrosis and test potential anti-fibrotic therapies.

Dr. Chu’s clinical research includes participation as site Principal Investigator and Co-Investigator in NIH-funded consortia, including a U01-funded project in pediatric acute liver failure and other industry-sponsored pediatric drug trials for genetic cholestatic liver disease, biliary atresia, and viral hepatitis. Her research has been awarded the Gilead Sciences Research Scholars Liver Disease Award, American Association for the Study of Liver Diseases (AASLD) Foundation Bridge Award, and funding from the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to examine the role of mannose metabolism in liver fibrosis. Dr. Chu is a member of the NIDDK Study Section for Fellowship Awards and was selected to serve as a member of the AASLD Task Force on COVID-19.

She received her BA magna cum laude from Harvard University and her MD from New York University School of Medicine. She completed her General Pediatrics residency training at Northwestern University/Children’s Memorial Hospital (now Lurie Children’s Hospital of Chicago) and her fellowship in Pediatric Gastroenterology, Hepatology, and Nutrition both at Children’s Memorial Hospital and at the Mount Sinai School of Medicine.

32 33

Jack Nash Professor of Rehabilitation Medicine

The Jack Nash Professor of Rehabilitation Medicine was established in 2004 through the generosity of The Peter Jay Sharp Foundation. The late Mr. Jack Nash, a Trustee of Mount Sinai for 22 years, fostered this relationship with the Foundation. The Nash family has long been among the most valuable and committed members of Mount Sinai’s community. Mr. Jack Nash, who joined the Boards of Trustees in 1990, passed on his tremendous tradition of philanthropy and service to his son Josh, who also became a Trustee in 2006. Numerous institutions in and around New York City have benefited from the Nash family’s visionary philanthropy. Their ongoing commitment to Mount Sinai can be seen through more than 35 years of generosity to clinical, research, and educational efforts across the Health System. The Jack Nash Professor of Rehabilitation Medicine is a fitting recognition of the state-of-the-art care that Mount Sinai provides.


KRISTEN DAMS-O’CONNOR, PhDJack Nash Professor of Rehabilitation Medicine

Kristen Dams-O’Connor, PhD, is Director of the Brain Injury Research Center of Mount Sinai and Professor in the Departments of Rehabilitation Medicine and Neurology at the Icahn School of Medicine at Mount Sinai.

Dr. Dams-O’Connor conducts multidisciplinary research dedicated to improving the lives of people living with brain injury. Her work aims to identify mechanisms, risk, and protective factors to improve long-term outcomes in individuals with traumatic

brain injury (TBI) and repetitive head trauma sustained through sports participation, military service, and intimate partner violence. Her team uses modern psychometric and statistical techniques to measure individual differences in trajectories of change over time among survivors of TBI. One goal of this work is to improve diagnosis of secondary post-traumatic conditions during life so they can be treated.

Dr. Dams-O’Connor also leads the Late Effects of TBI Project, a TBI brain donor program focused on characterizing the clinical phenotype and postmortem pathological signatures of post-traumatic neurodegeneration and their associations with Alzheimer’s disease and related dementias. She is Project Director of the New York Traumatic Brain Injury Model System of Care, one of 16 centers of excellence for TBI research and clinical care in the United States.

Her research is supported by federal grants from the National Institutes of Health, the National Institute on Disability, Independent Living, and Rehabilitation Research, the United States Department of Defense, the Centers for Disease Control and Prevention, and the Patient-Centered Outcomes Research Institute. Dr. Dams-O’Connor has published more than 150 manuscripts and chapters on TBI treatments and outcomes, and has presented her research internationally.

34 35

Mount Sinai Chair in Artificial Intelligence and Human Health



THOMAS J. FUCHS, Dr.sc.Mount Sinai Chair in Artificial Intelligence and Human Health

Thomas J. Fuchs, Dr.sc. is a scientist in the groundbreaking field of computational pathology, focused on the use of artificial intelligence (AI) to analyze images of tissue samples to identify disease, recommend treatment, and predict outcome. In October 2020, he was appointed Co-Director of the Hasso Plattner Institute for Digital Health at Mount Sinai, Dean of Artificial Intelligence and Human Health, and Professor of Computational Pathology and Computer Science at the Icahn School of Medicine at Mount Sinai. In this role, Dr. Fuchs leads the next generation of scientists and

clinicians using artificial intelligence and machine learning to develop novel diagnostics and treatments for acute and chronic disease. Dr. Fuchs’s work includes developing novel methods for analysis of digital microscopy slides to better understand genetic mutations and their influence on changes in tissues. He has been recognized for developing large-scale systems for mapping the pathology, origins, and progress of cancer. This breakthrough was achieved by building a high-performance compute cluster to train deep neural networks at petabyte scale.

Before joining Mount Sinai, Dr. Fuchs was Director of the Warren Alpert Center for Digital and Computational Pathology at Memorial Sloan Kettering Cancer Center (MSK) and Associate Professor at Weill Cornell Graduate School for Medical Sciences. At MSK, he led a laboratory focused on computational pathology and medical machine learning. Dr. Fuchs also co-founded Paige.AI in 2017 and led its initial growth to the leading AI company in pathology. He is a former research technologist at NASA’s Jet Propulsion Laboratory and visiting scientist at the California Institute of Technology. Dr. Fuchs holds a Doctor of Science in Machine Learning from ETH Zurich and a MS in Technical Mathematics from Graz Technical University in Austria.

36 37

Jean C. and James W. Crystal Professor of Genomics

The Jean C. and James W. Crystal Professor of Genetics and Genomics Sciences was established in 2010 by James W. and Jean C. Crystal, long-time philanthropists, advocates, and volunteers. Mr. Crystal is Vice Chairman and Board Director of Alliant Insurance Services. He has been a member of the Mount Sinai Boards of Trustees since 1982, serves as co-chair of the Audit and Compliance Committee, and is a member of the Finance and Executive Committees. Mrs. Crystal joined the Boards of Trustees in 1996 after serving as president of the Mount Sinai Auxiliary Board. She is a member of the Community and Government Affairs Committee and the Committee on Quality. Mrs. Crystal also created Mount Sinai’s vital Ambassadors Program, which is staffed by volunteers who provide guidance for patients throughout the institution. The Crystals also have a strong commitment to adolescent medicine; Mrs. Crystal served as chair of the Mount Sinai Adolescent Health Center Advisory Board, and in 2001, they endowed the Jean C. and James W. Crystal Professor of Adolescent Health.


ALLISON M. GOATE, DPhilJean C. and James W. Crystal Professor of Genomics

Alison M. Goate, DPhil, is the Jean C. and James W. Crystal Professor of Genomics and Chair of the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. She has worked on the genetics of neurodegenerative diseases including Alzheimer’s disease (AD) and Frontotemporal Dementia (FTD) since 1987, and is the founding director of the Ronald M. Loeb Center for Alzheimer’s Disease at Mount Sinai.

Over the last three decades, Dr. Goate has been part of many gene finding teams that have successfully identified disease-causing variants for both AD and FTD. While working at Imperial College in London, she reported the first mutation to cause familial Alzheimer’s disease, and her early studies at Washington University in St. Louis identified a genetic mutation in Colombian families that are now part of the Alzheimer’s Prevention Initiative clinical trial. Her lab was also part of the team that first reported MAPT mutations in FTD.

Dr. Goate is also a leader in the study of late onset AD genetics using integrative genomic approaches to identify novel genetic risk factors. Her work led to the identification of Trem2 as a risk factor for AD and has highlighted the enrichment of AD risk variants in microglial enhancers, regulatory elements in DNA that control gene expression in immune cells of the brain. Dr. Goate is now building upon these insights using genome editing in induced pluripotent stem cells to understand the molecular mechanisms of disease and to develop novel therapeutics.

Dr. Goate has received the Potamkin Award, the Khalid Iqbal Lifetime Achievement Award from the Alzheimer’s Association, and the MetLife Award for her research on AD. She was elected a fellow of the American Association for the Advancement of Science in 2012, and a fellow of the National Academy of Medicine in 2016.

38 39

Mount Sinai Professor in Neuroimaging of Addiction



RITA Z. GOLDSTEIN, PhDMount Sinai Professor in Neuroimaging of Addiction

Rita Z. Goldstein, PhD, is a Professor of Psychiatry with a secondary appointment in the Department of Neuroscience at the Icahn School of Medicine at Mount Sinai. Dr. Goldstein is Chief of the Neuropsychoimaging of Addiction and Related Conditions research group.

Nationally and internationally known for her neuroimaging and neuropsychological studies in drug addiction, Dr. Goldstein formulated a theoretical model known as

Impaired Response Inhibition and Salience Attribution (iRISA). Multiple neuroimaging modalities—including MRI, EEG/ERP, PET—and neuropsychological tests are used to explore the neurobiological underpinnings of iRISA in drug addiction and related conditions. This model has drawn considerable scientific attention (exceeding 2,850 for a review published in the American Journal of Psychiatry in 2002 and 1,970 for another review published in Nature Reviews Neuroscience in 2011). An important application of Dr. Goldstein’s research is to facilitate the development of intervention modalities that would improve cognitive and emotional function, leading to better treatment outcomes in drug addiction and other chronically relapsing disorders of self-regulation.

Dr. Goldstein has authored or co-authored more than 145 highly-cited, peer-reviewed manuscripts and book chapters focusing on the role of the prefrontal cortex in drug addiction. Her research has been independently funded by several federal and private agencies, with total funding of more than $20 million as a principal or multiple investigator or program director. She became a fellow of the American College of Neuropsychopharmacology in 2015, receiving the prestigious Joel Elkes Research Award in 2012 and the Jacob P. Waletzky Award in 2013.

Mentoring is a high priority for Dr. Goldstein. She has mentored numerous trainees, spanning from postdoctoral fellows to graduate, undergraduate, and high school students. Her trainees have published many first authorship manuscripts in top psychiatry and neuroscience journals, have become principal investigators on their own NIH-funded grants, and many of them are now leading independent research labs at prestigious institutions.

Dr. Goldstein earned an undergraduate degree from Tel Aviv University in Israel. She received her PhD in Health Clinical Psychology from the University of Miami after completing a yearlong internship in clinical neuropsychology at the Long Island Jewish Medical Center. She then completed her postdoctoral training on brain imaging and alcohol abuse through a fellowship from the National Institutes of Health at Brookhaven National Laboratory.

40 41

Waldman Chair of Dermatology

The Waldman Chair of Dermatology was established in 2016 through the generosity of Kimberly and Eric J. Waldman. The Waldmans are continuing a family tradition of philanthropy, leadership, and service. Eric has been a Mount Sinai Trustee since 2009. In 2014, the Waldmans made a generous gift to name the Kimberly and Eric J. Waldman Department of Dermatology to help ensure the Department’s place as a global leader in the study and treatment of skin diseases.


EMMA GUTTMAN-YASSKY, MD, PhDWaldman Chair of Dermatology

Emma Guttman-Yassky, MD, PhD, is the Waldman Professor and System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai. A world-renowned dermatologist and physician scientist, Dr. Guttman-Yassky divides her time between a busy clinic and her laboratory that investigates the mechanisms underlying inflammatory skin diseases, leading to novel treatments for these patients.

Dr. Guttman-Yassky’s major clinical and research area of expertise is inflammatory skin diseases, with major focus on eczema/atopic dermatitis (AD) and alopecia areata, as well as other inflammatory skin diseases. She made paradigm-shifting discoveries on the immunologic basis of AD/eczema in humans, opening the door to new therapeutics. Dr. Guttman has developed the only comprehensive molecular maps of AD, defining skin differentiation and immune-circuits characterizing this disease. Her research on atopic dermatitis/eczema has contributed to many of the recently developed treatments for this disease, earning her a unique place as one of the leaders in dermatology and immunology worldwide. She has also shown that AD is a complex disease with distinct phenotypes based on ethnicity, age, and other factors. She has shown that atopic dermatitis in Asian and African American patients is different from atopic dermatitis in European American patients, with important therapeutic implications. She is now testing (both clinically and mechanistically) multiple targeted-therapeutics for atopic dermatitis. She has recently also extended her research interest to alopecia areata in which her findings are also translated to novel therapeutic targets.

Dr. Guttman-Yassky is considered one of the world’s leading experts in inflammatory skin diseases and authored more than 250 articles and is often invited as a keynote and plenary speaker to multiple international and national meetings. She co-founded the International Eczema Council, for which she functions as immediate past president. This organization now comprises the vast majority of top experts in atopic dermatitis/eczema worldwide. She is also on the scientific advisory board of the National Eczema Association and the board of the American Skin Association. She was also elected to the American Society for Clinical Investigation and the American Dermatological Society, and she has received the Young Investigator Award from the American Academy of Dermatology, the Bettina C. Hilman, MD Lectureship and Award from the American Academy of Allergy and Immunology that honors a pioneer in allergy research whose contributions to science and medicine impacted patients’ lives, the Donald Y. M. Leung, MD, PhD-JACI Editors Lectureship and Faculty Development Award, and many other awards.

She earned her MD from Sackler at the Tel-Aviv University, and a PhD degree from the Bar-Ilan University, Israel. After her Israeli Board certification in dermatology in Israel, Dr. Guttman-Yassky moved to the U.S. for a postdoctoral fellowship at The Rockefeller University. She then became board-certified in the U.S. after a second dermatology residency training at Weill Cornell Medical College.

42 43

Irene and Dr. Arthur M. Fishberg Professor of Medicine

During their lifetimes, Arthur M. Fishberg, MD, and his wife, Irene, were integral members of the Mount Sinai family. Dr. Fishberg was a distinguished nephrologist and a leading authority on hypertension. His longstanding, devoted professional affiliation with Mount Sinai commenced in 1926 when he began his residency. When Mount Sinai School of Medicine opened in 1963, Dr. Fishberg was appointed Clinical Professor of Medicine and served in this capacity until 1977. For his pioneering spirit, far-reaching professional achievements, and service to the institution, he received the Jacobi Medallion in 1978, The Mount Sinai Alumni Association’s most coveted award, and in 1979 was bestowed an honorary Doctor of Science degree from the School of Medicine. Dr. Fishberg also had a passion for research, which he translated into the Irene and Dr. Arthur M. Fishberg Professor of Medicine endowment, established by his estate in 1993. There are currently nine Fishberg Professorships of Medicine at Mount Sinai.


GIRISH N. NADKARNI, MDIrene and Dr. Arthur M. Fishberg Professor of Medicine

Girish N. Nadkarni, MD, MPH, is Associate Professor of Medicine (Nephrology) with tenure at the Icahn School of Medicine at Mount Sinai. As an expert physician-scientist, Dr. Nadkarni bridges the gap between comprehensive clinical care and innovative research. He is the Chief of the Division of Data Driven and Digital Medicine (D3M), the Co-Chair of the Executive Management Team of the Mount Sinai Clinical Intelligence Center (MSCIC), the Clinical Director of the Hasso Plattner Institute for Digital Health at Mount Sinai, as well as a core faculty member

in the Charles Bronfman Institute for Personalized Medicine.

Before completing his medical degree at one of the top-ranked medical colleges in India, Dr. Nadkarni received training in mathematics. He then received a master’s degree in public health at the Johns Hopkins Bloomberg School of Public Health, and then was a research associate at the Johns Hopkins Medical Institute. Dr. Nadkarni completed his residency in internal medicine and his clinical fellowship in nephrology at the Icahn School of Medicine at Mount Sinai. He then completed a research fellowship in personalized medicine and informatics at the Charles Bronfman Institute for Personalized Medicine, where he was mentored by Dr. Erwin Bottinger.

Dr. Nadkarni has authored more than 200 peer-reviewed scientific publications, including articles in the New England Journal of Medicine, the Journal of the American Medical Association, the Annals of Internal Medicine and Nature Medicine. Dr. Nadkarni is the principal or co-investigator for several grants funded by the National Institutes of Health focusing on informatics, data science, and precision medicine. He is also one of the multiple principal investigators of the NIH RECOVER consortium focusing on the long term sequelae of COVID-19. He has several patents, and is also the scientific co-founder of investor-backed companies—one of which, Renalytix, is listed on NASDAQ. In recognition of his work as an active clinician and investigator, he has received several awards and honors, including the Dr. Harold and Golden Lamport Research Award and the Deal of the Year Award from Mount Sinai Innovation Partners for his work with Renalytix.

44 45

Shelley and Steven Einhorn Distinguished Chair of Ophthalmology

The Shelley and Steven Einhorn Distinguished Chair of Ophthalmology was established through the generosity of Steven and Shelley Einhorn. The Einhorns have been dedicated supporters of Mount Sinai for more than 20 years, and their leadership has significantly enhanced our research and clinical operations. In addition to this Chair, the Einhorns’ visionary philanthropy created The Shelley and Steven Einhorn Clinical Research Center at New York Eye and Ear Infirmary of Mount Sinai (NYEE), which is devoted to clinical research into the causes and treatment of glaucoma, and the Shelley and Steven Einhorn Laboratory for Experimental Cancer Therapeutics, a multidisciplinary research hub within The Tisch Cancer Institute.


LOUIS R. PASQUALE, MD, FARVOShelley and Steven Einhorn Distinguished Chair of Ophthalmology

Louis R. Pasquale, MD, FARVO, joined Mount Sinai in 2018 as Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai and Site Chair of Ophthalmology at The Mount Sinai Hospital and Mount Sinai Queens. Prior to joining Mount Sinai, he worked at Massachusetts Eye and Ear, a teaching hospital of Harvard Medical School, for 25 years. There, he rose to the rank of Professor of Ophthalmology and Distinguished Scholar in Ophthalmology at Harvard Medical School as well as Director of the Glaucoma Service at Massachusetts Eye and Ear.

With continuous support from the National Institutes of Health since 2006, Dr. Pasquale’s research has focused on the discovery of primary prevention strategies in open-angle glaucoma. His work has highlighted the role of environmental risk factors for exfoliation syndrome and the importance of nitric oxide signaling in primary open-angle glaucoma. He has also contributed to resolving the complex genetic architecture of primary open-angle glaucoma. His work is highly impactful with more than 309 publications in PubMed and an h-index of 68.

Dr. Pasquale is a member of the editorial boards of Ophthalmology Glaucoma, International Glaucoma Review, Asia-Pacific Journal of Ophthalmology, and the American Journal of Ophthalmology. He served as a member of the National Institutes of Health’s National Advisory Eye Council. He is currently the Association for Research in Vision and Ophthalmology (ARVO) Glaucoma Section Trustee and a Gold Fellow of ARVO. Finally, he is a member of the American Ophthalmological Society and the Glaucoma Research Society.

Dr. Pasquale earned his medical degree at the State University of New York Stony Brook School of Medicine. He completed an internal medicine internship at Bronx Municipal Hospital, an ophthalmology residency at Temple Unversity Hospital, and a two-year fellowship in glaucoma at Johns Hopkins School of Medicine.

46 47

Mount Sinai Professor in Women’s Health Research



LESLEE J. SHAW, PhDMount Sinai Professor in Women’s Health Research

Leslee J. Shaw, PhD, is an internationally recognized cardiovascular outcomes researcher, with a strong focus on women’s health that encompasses quality, equity, and evaluation of cardiovascular diseases such as atherosclerosis in women. Before joining the Icahn School of Medicine at Mount Sinai in 2021, she directed the Dalio Institute at Weill Cornell Medical College. Prior to her time at Weill Cornell, Dr. Shaw held the R. Bruce Logue Professorship at the Emory University School of Medicine.

At Mount Sinai, Dr. Shaw holds a triple primary appointment in Medicine (Cardiology), Population Health Science and Policy, and Obstetrics, Gynecology and Reproductive Science, and serves as Director of The Blavatnik Family Women’s Health Research Institute. Through this arrangement, Dr. Shaw will expand upon the Institute’s goals for interdisciplinary collaboration in women’s health, and her strong commitment to mentoring and faculty development will enhance collaboration with junior faculty within the Institute.

Dr. Shaw has published more than 760 publications and presented more than 400 abstracts in major scientific meetings in the United States, Europe, Asia, and South America. She has been ranked for more than a decade as one of the top 1 percent of clinical researchers with the most highly cited publications, awarded by Thomson Reuters. Based on her scientific contributions, Dr. Shaw received from the American College of Cardiology the Simon Dack Award for academic excellence in 2009, and, in 2013, the Coalition to Reduce Disparities in Cardiovascular Disease Outcomes Award for her studies on racial and ethnic differences in cardiovascular disease. Also in 2013, she received the Women’s Day Red Dress Award for her scientific contributions to women’s health. Recently, in 2020, Dr. Shaw was awarded the Bernadine Healy Leadership Award in Women’s Cardiovascular Disease from the American College of Cardiology, the Nanette Wenger Award from the American Society of Preventive Cardiology, and the Distinguished Investigator Award from the Academy for Radiology and Biomedical Imaging Research.

48 49

Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics

The Chemotherapy Foundation generously established this professorship in 1997 in recognition of the late Dr. Ezra Greenspan’s pioneering work in developing innovative cancer therapies and his inspiring leadership as The Foundation’s founder, chairman, and medical director. Dr. Greenspan completed his internship and residency at Mount Sinai and, after two years at the National Cancer Institute, spent most of his 50-year career here. In addition to being a superb clinician and patient advocate, his most prominent contribution to cancer care was in demonstrating that by using combinations of drugs, clinicians could make significant gains in the treatment of cancer. Contributing to the creation of this professorship were leadership gifts from Pearl B. Kalikow, Ronnie and Sam Heyman, The Isaac Lieber Family Foundation, and designated gifts from Foundation supporters.


JOSEPH A. SPARANO, MDEzra M. Greenspan, MD Professor in Clinical Cancer Therapeutics

Joseph A. Sparano, MD, an internationally-recognized expert in the management of breast cancer and HIV-associated malignancies, is Chief of the Division of Hematology and Medical Oncology for the Mount Sinai Health System and Deputy Director of The Tisch Cancer Institute. Dr. Sparano joined Mount Sinai in 2021 following a distinguished 33-year career at the Albert Einstein College of Medicine and Montefiore Medical Center, where he was Professor of Medicine and Obstetrics & Gynecology and Women’s Health, Associate Chairman for Clinical Research in the

Department of Oncology, and Associate Director for Clinical Research at the Albert Einstein Cancer Center.

Dr. Sparano led a breakthrough clinical trial in breast cancer research, the Trial Assigning Individualized Options for Treatment, known as TAILORx—the first and largest National Cancer Institute (NCI) precision medicine trial. It integrated the 21-gene expression assay into clinical decision making for adjuvant therapy of early stage ER-positive, HER2-negative breast cancer. The trial led to changes in treatment guidelines from both the American Society of Clinical Oncology and the National Comprehensive Cancer Network. TAILORx results were published in the New England Journal of Medicine in 2015, 2018, and 2019. Dr. Sparano also led an effort to develop and validate a new tool integrating clinical and genomic information to guide adjuvant therapy for breast cancer which became freely available for widespread clinical use after publication in the Journal of Clinical Oncology in 2021. Evidence generated from another trial that he led which evaluated the role of taxane therapy in early breast cancer, published in the New England Journal of Medicine in 2008, has also had an important and enduring impact on standard clinical practice guidelines.

Dr. Sparano has conducted impactful studies aimed at improving the outcomes of HIV positive patients with cancer, including research on novel approaches for treating non-Hodgkin lymphoma and anal cancer in individuals with HIV. He has also focused his research on improving racial disparities in cancer care and on cancer metastasis. Dr. Sparano’s research has been funded by the NCI as well as the Breast Cancer Research Foundation, Susan G. Komen Foundation, and V Foundation.

Dr. Sparano is Chair and Principal Investigator of the AIDS Malignancy Consortium, a network of clinical trial sites in the U.S., Africa, and Latin America. He serves as Deputy Chair of the Eastern Cooperative Oncology Group (ECOG)-American College of Radiology Imaging Network Cancer Research Group, and is a member of the Board of Managers of the PreECOG Research Foundation and the Early Breast Cancer Trialists’ Collaborative Group Steering Committee. He is a recipient of some of the most prestigious awards in the field of medical oncology, including the ECOG Young Investigator Award, the Charles Moertel Award and Lecture by the Alliance for Cancer Clinical Trials, the American Association for Cancer Research William L. McGuire Award and Lecture, and the American Society of Clinical Oncology Gianni Bonadonna Award and Lecture.

50 51

The Arthur and Janet C. Ross Professor of Medicine

Mount Sinai has benefited greatly from its long-time relationship with the late Arthur Ross and his wife, Janet C. Ross, two of New York’s most magnanimous philanthropists. Mr. Ross was Vice Chairman of Central National-Gottesman, a distributor of pulp, paperboard, and newsprint to more than 75 countries. Mr. Ross was elected to The Mount Sinai Boards of Trustees in 1971, and served with distinction as a Life Trustee until his passing in 2007. In addition to establishing this professorship, Arthur and Janet C. Ross supported a number of research areas within Mount Sinai over the years, including dermatology, cardiology, and neurology.


FILIP K. SWIRSKI, PhDThe Arthur and Janet C. Ross Professor of Medicine

Filip K. Swirski, PhD, is the Arthur and Janet C. Ross Professor of Medicine and Professor of Diagnostic, Molecular and Interventional Radiology as well as Director of the Cardiovascular Research Institute at the Icahn School of Medicine at Mount Sinai. He has secondary appointments at the Precision Immunology Institute and the BioMedical Engineering and Imaging Institute. Dr. Swirski obtained his PhD at McMaster University in Hamilton, Canada, and postdoctoral studies at Brigham and Women’s Hospital in Boston. Dr. Swirski was Professor at Harvard Medical School

and Principal Investigator at Massachusetts General Hospital before joining Mount Sinai in 2021.

Dr. Swirski has been recognized nationally and internationally as a leader in the field of innate immunity and inflammation in disease. He focuses on fundamental and translational cardiovascular science within the context of the hematologic, immune, metabolic, and nervous systems, with specific emphasis on cell development, communication, and function. Recently, his work has expanded to include lifestyle factors such as sleep, diet, and stress as critical modulators of cardiovascular health and hematopoiesis.

Dr. Swirski is a highly cited researcher and is the recipient of numerous awards, including the Jeffrey M. Hoeg Award from the American Heart Association, the William Harvey Lecture from the European Society of Cardiology, the Martin Prize for Fundamental Research, and the Howard M. Goodman Fellowship, and he was also the Patricia and Scott Eston Research Scholar at Massachusetts General Hospital. Dr. Swirski has been continuously funded by the National Institutes of Health. He holds an Outstanding Investigator Award from the National Heart, Lung, and Blood Institute, an Established Investigator Award from the American Heart Association, and is the North American Coordinator of a Leducq Foundation Transatlantic Network of Excellence Consortium.

52 53

Mount Sinai Professor in Psychiatry and Neuroscience of Trauma



RACHEL YEHUDA, PhDMount Sinai Professor in Psychiatry and Neuroscience of Trauma

Rachel Yehuda, PhD, is Professor and Vice Chair of Psychiatry for Veterans Affairs, and Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai. She is also the Mental Health Director at the Bronx Veterans Affairs Medical Center.

A recognized leader in the field of traumatic stress studies, Dr. Yehuda has authored more than 500 papers and received numerous grants and awards in the field of traumatic stress and the neuroscience of post-traumatic stress disorder (PTSD).

Throughout her career, her research has focused on the study of the enduring effects of trauma exposure in multiple populations such as combat veterans, Holocaust survivors, and victims of 9/11 and interpersonal violence. These studies have examined the relationship between the biological and psychological changes associated with trauma.

Dr. Yehuda’s pioneering work has resulted in an understanding of the epigenetic changes associated with trauma and PTSD, and also molecular alterations in association with intergenerational trauma. Dr. Yehuda’s laboratory has investigated novel treatment approaches for PTSD and the biological factors that may contribute to differing treatment outcomes for the purpose of developing personalized medicine strategies for treatment matching in PTSD. This work has resulted in an approved U.S. patent for a PTSD blood test. Her laboratory is also using advances in stem cell technology to examine PTSD gene expression networks in induced neurons. Most recently, Dr. Yehuda established the Center for Psychedelic Psychotherapy and Trauma Research at Mount Sinai, which integrates sophisticated brain imaging and molecular neuroscience in PTSD with clinical trials using psilocybin and MDMA-assisted psychotherapy and other related medicines.

54 55

Willard T.C. Johnson Research Professor of Neurogenetics

The Willard T.C. Johnson Research Professorship was established in 1984 by the Robert Wood Johnson Foundation (RWJF) to support research of Alzheimer’s and other neurogenetic diseases. RWJF is the United States’ largest philanthropy focused solely on health and has supported a variety of initiatives at Mount Sinai since the Foundation’s inception in 1973. The professorship was named for the late great grandson of Johnson & Johnson co-founder Robert Wood Johnson.


BIN ZHANG, PhDWillard T.C. Johnson Research Professor of Neurogenetics

Bin Zhang, PhD, is a Professor of Genetics and Genomic Sciences and the Director of the Center for Transformative Disease Modeling at the Icahn School of Medicine at Mount Sinai. Prior to joining Mount Sinai, Dr. Zhang worked as a Principal Scientist and Group Leader of Network Biology at Sage Bionetworks, a non-profit research organization that grew out of Rosetta Inpharmatics, a wholly owned subsidiary of Merck & Co. Dr. Zhang earned his PhD and a master’s degree in Computer Science from the State University of New York at Buffalo, a master’s degree in electronic

engineering from Tsinghua University, Beijing, China, and a bachelor’s degree in electrical engineering from Tongji University, Shanghai, China.

Dr. Zhang’s extensive experience in electrical engineering and computer science empowers him to build highly predictive models for very complex data from handwritten document images to large-scale disease multi-Omics data. His expertise lies in data mining, pattern recognition, and systems biology. Over the past decade, Dr. Zhang has developed a series of influential gene network inference algorithms which have been extensively used for identification of novel pathways and gene targets, as well as development of drugs for human diseases such as cancer, Alzheimer’s, obesity, and diabetes.

Dr. Zhang is leading the effort of integrative multiscale network biology modeling of large-scale multi-Omics data in complex human diseases including cancer, diabetes, depression, Parkinson’s disease, Alzheimer’s disease, influenza and Zika infection, and COVID-19, as well as pollution-induced asthma. Building upon highly robust and predictive mechanistic network models underlying these diseases, he is developing novel therapeutics for these illnesses using the state-of-the-art artificial intelligence and machine learning approaches.

A prolific researcher, Dr. Zhang has published 190 papers including a number of high profile papers in Nature, Science, Cell, and Nature Genetics. His research on cancer established the first set of data driven predictive gene network models and driver genes of molecular alterations in breast cancer, primary melanoma, and gastric cancer. Such effort has been extended to more than 30 cancer types. His research on the genetic networks and regulators of Parkinson’s disease opens up a new avenue for studying the disease. His research that uncovered an immune/microglia gene network causally linked to Alzheimer’s disease (AD) was published in Cell in 2013 and selected by the Journal of Alzheimer’s Disease as one of the top 50 most influential papers on AD published from 2013 to 2017. His subsequent research in this direction further systematically identified molecular signatures underlying selective regional vulnerability to AD and reconstructed neuronal gene subnetworks dysregulated in AD. More importantly, he recently uncovered three major molecular subtypes of AD, which are independent of age and disease stage. Novel compounds are being developed for targeting the network models and key drivers of AD. These studies led by Dr. Zhang provide a foundation for determining more effective biomarkers for early prediction of AD, studying causal mechanisms of AD, developing next generation therapeutics for AD, and designing more effective and targeted clinical trials, ultimately leading to precision medicine for AD.

56 57

Boards of Trustees Mount Sinai Health System

CO-CHAIRMENRICHARD A. FRIEDMANJAMES S. TISCH

CHAIRMAN EMERITUSPETER W. MAY

Andrew M. AlperGlenn R. AugustFrank J. BisignanoLeon D. BlackJeff T. BlauThomas R. BlockHenry M. CalderonAnthony CancellieriGerald J. CardinaleEdith W. CooperHenry CornellJames W. CrystalJean C. CrystalEdgar M. Cullman, Jr.Susan R. CullmanBonnie M. Davis, MDEva Andersson Dubin, MD Glenn DubinJoel S. EhrenkranzJoseph J. FennessyEric J. FriedmanRobert FriedmanRaquel K. GilinskiArne GlimcherDonald J. GogelDavid S. GottesmanScott Gottlieb, MDMichael S. GrossVicki GrossJoshua J. HarrisKimberley D. HarrisJohn B. HessSteven HochbergAmaziah HowellCarl C. IcahnGail Golden IcahnHamilton E. JamesBrad KarpJames L. KempnerThomas L. Kempner, Jr.

Michelle Kang Kim, MD, PhDMichael KleinHenry R. KravisA. Gale KroegerEric S. LaneJohn A. LevinAnton LevyMarc S. LipschultzDaniel S. LoebDina Powell McCormickKenneth B. MehlmanEric MindichMichael MinikesNeil S. MitchellJoshua NashJames NearyAlice NetterBernard W. NussbaumLee OleskyPeter R. OrszagZibby OwensLewis C. PellJoel I. PicketBettina B. PlevanJoseph J. PlumeriRichard RavitchJudith O. Rubin Hon. Robert E. RubinJoshua RuchEric M. RuttenbergAlejandro Santo DomingoDenise SaulRobert F. Savage Jr.Amy SchulmanStephen L. SchwartzAdam ShapiroThomas W. StraussHon. William C. Thompson, Jr.Michael J. UrfirerEric WaldmanDavid E. Wheadon, MDDavid WindreichJohn S. WinklemanWilliam H. Wright IIDavid M. ZaslavMichael J. Zimmerman

EX OFFICIOSMichael S. GrossVicki GrossA. Gale KroegerJoanne Stone, MD

PHYSICIAN REPRESENTATIVESJeanne B. Albu, MDBrett Bernstein, MDLouis R. DePalo, MDRichard B. Rosen, MD

EMERITUS TRUSTEESBobbie AbramsCharles R. BronfmanWilliam M. EllinghausJane FriedmanJerome R. GoldsteinRichard A. GoldsteinJudah GribetzGeorge J. Grumbach, Jr.Merrill M. HalpernLawrence S. HuntingtonLewis P. JonesEllen KatzStanley KomaroffJo Carole LauderEugene Mercy Jr.Carl M. MuellerJoan SarnoffEdie Schur


The Icahn School of Medicine at Mount Sinai advances science, medicine, and health care delivery for the benefit of humanity through a culture of excellence, innovation, collaboration, and inclusive diversity. We conduct groundbreaking research; educate and nurture the next generation of exceptional clinicians, researchers, teachers, and leaders; and deliver the most advanced compassionate care with an unwavering commitment to health equity.

Mission Statement

2021 - icahn.mssm.edu

Documents